Dynamic Simulations of Pathways Downstream of ERBB-Family, Including Mutations and Treatments: Concordance with Experimental Results

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|7|737-757

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.7, 2010-11, pp. : 737-757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 241-242

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM proteases, ErbB pathways and cancer

By Zhou Bin-Bing S   Fridman Jordan S   Liu Xiangdong   Friedman Steve M   Newton Robert C   Scherle Peggy A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 591-606

Informa Healthcare

Access to resources Recommend Favorite

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

By  

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-11 ,pp. : 775-793

Bentham Science Publishers

Access to resources Recommend Favorite

The medical treatment of overactive bladder, including current and future treatments

By Athanasopoulos Anastasios   Cruz Francisco  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1041-1055

Informa Healthcare

Access to resources Recommend Favorite

Allergic rhinitis: meaningful and less meaningful combination treatments including reminiscences

By Szelenyi I.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 6, 2014-06 ,pp. : 414-416

Govi-Verlag

Access to resources Recommend Favorite